Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.39 |
| ▸ | KIF11 | P52732 | 2/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | PGK1 | P00558 | 1/20 | 0.33 |
| ▸ | PGK2 | P07205 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7670356 | 0.85 | TAAR1 (0.33) | TSHRALDH1A1PTPN1KIF11TAAR1 | |
| SCHEMBL16933884 | 0.78 | TSHR (0.52) | TSHRALDH1A1PTPN1CA1CA2 | |
| SCHEMBL507483 | 0.76 | TSHR (0.50) | TSHRALDH1A1PTPN1DAOCA1 | |
| SCHEMBL2653057 | 0.76 | TSHR (0.50) | TSHRALDH1A1PTPN1DAOCA1 | |
| SCHEMBL28758503 | 0.76 | TSHR (0.57) | TSHRALDH1A1PTPN1CA1CA2 | |
| SCHEMBL10415351 | 0.76 | TSHR (0.50) | TSHRALDH1A1PTPN1DAOCA1 | |
| SCHEMBL506977 | 0.76 | TAAR1 (0.52) | TSHRALDH1A1PTPN1DAOCA1 | |
| SCHEMBL2281974 | 0.76 | TSHR (0.50) | TSHRALDH1A1PTPN1DAOCA1 | |
| SCHEMBL6988143 | 0.76 | TSHR (0.50) | TSHRALDH1A1PTPN1DAOCA1 | |
| SCHEMBL13440 | 0.76 | TSHR (0.50) | TSHRALDH1A1PTPN1DAOCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114583088-A | Quantum dot light-emitting diode and preparation method thereof | TCL科技集团股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| WO-2022111583-A1 | QUANTUM DOT LIGHT-EMITTING DIODE AND PREPARATION METHOD THEREFOR | TCL科技集团股份有限公司 | 2022-06-02 | — | — | WO | claimed |
| US-8283357-B2 | Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds | GILEAD SCIENCES, INC. (US) | 2012-10-09 | — | — | US | claimed |
| EP-2440517-A2 | CYCLOALKYLCARBAMATE BENZAMIDE ANILINE HDAC INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2012-04-18 | — | — | EP | claimed |
| EP-2318363-A1 | HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS | Nuevolution A/S (DK) | 2011-05-11 | — | — | EP | claimed |
| WO-2010144378-A2 | CYCLOALKYLCARBAMATE BENZAMIDE ANILINE HDAC INHIBITOR COMPOUNDS | GILEAD COLORADO, INC. (US) | 2010-12-16 | — | — | WO | claimed |
| US-20100311794-A1 | CYCLOALKYLCARBAMATE BENZAMIDE ANILINE HDAC INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-12-09 | — | — | US | claimed |
| WO-2009152824-A1 | HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS | NUEVOLUTION A/S (DK) | 2009-12-23 | — | — | WO | claimed |
| CN-117024366-B | Preparation method of dihydropyrazole compound containing quaternary carbon center | 安徽中医药大学 | 2025-05-02 | — | — | CN | disclosed |
| WO-2024237014-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | 株式会社日本触媒 | 2024-11-21 | — | — | WO | disclosed |
| WO-2024101336-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | 国立大学法人京都大学 | 2024-05-16 | — | — | WO | disclosed |
| CN-117897416-A | Copolymer and resin composition | 大金工业株式会社 | 2024-04-16 | — | — | CN | disclosed |
| CN-114805238-A | Preparation process of aprepitant intermediate | 苏州诚和医药化学有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114583088-A | Quantum dot light-emitting diode and preparation method thereof | TCL科技集团股份有限公司 | 2022-06-03 | — | — | CN | disclosed |
| US-5410084-A | Diamine having perfluoro group; colorless, transparent, heat resistant,low dielectric constant | MITSUI TOATSU CHEMICALS, INC. (JP) | 1995-04-25 | — | — | US | disclosed |
| US-5354839-A | Low dielectric constant, colorless, transparent and excellent in processability and heat resistance | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1994-10-11 | — | — | US | disclosed |
| EP-0565352-A2 | Aromatic diamine and polyimde, and preparation process of same | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-10-13 | — | — | EP | disclosed |
| EP-0537318-A1 | NEW NON-HYGROSCOPIC MONO-AMMONIUM SALTS. | ALKALOIDA VEGYESZETI GYAR (HU) | 1993-04-21 | — | — | EP | disclosed |
| WO-1992018513-A1 | NEW NON-HYGROSCOPIC MONO-AMMONIUM SALTS | ALKALOIDA VEGYÉSZETI GYÁR RT. (HU) | 1992-10-29 | — | — | WO | disclosed |
| EP-0206951-A2 | Process for the perfluoroalkylation of aromatic derivatives | RHONE-POULENC CHIMIE (FR) | 1986-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311794-A1 | CYCLOALKYLCARBAMATE BENZAMIDE ANILINE HDAC INHIBITOR COMPOUNDS | HDAC1, HDAC5, HDAC3 | TSHR 4008/4885ALDH1A1 739/4885PTPN1 4306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.